Max Näder Lab for Rehabilitation Technologies & Outcomes Lab, Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago), Chicago, IL; Center for Bionic Medicine, Shirley Ryan AbilityLab, Chicago, IL.
Center for Rehabilitation Outcomes Research, Shirley Ryan AbilityLab, Chicago, IL.
Arch Phys Med Rehabil. 2021 Feb;102(2):233-244. doi: 10.1016/j.apmr.2020.08.013. Epub 2020 Sep 22.
To evaluate the potential of a microprocessor swing and stance controlled knee-ankle-foot orthosis (MPO) to improve balance, functional mobility, and quality of life in individuals with lower-extremity impairments as compared to a stance-control-orthosis (SCO) and conventional knee-ankle-foot orthosis (KAFO) over a use-period of a month.
Randomized crossover study.
Ambulatory research laboratory and home and community for community-dwelling adults.
Persons (N=18) who actively used a unilateral KAFO or SCO for impairments due to neurologic or neuromuscular disease, orthopedic disease, or trauma.
Participants were trained to acclimate and use SCO and MPO.
The 6-minute walk test (6MWT), 10-m walk test, Berg Balance Scale (BBS), functional gait assessment (FGA), hill assessment index, stair assessment index (SAI), Five Times Sit to Stand Test, crosswalk test, Modified Falls Efficacy Scale, Orthotic and Prosthetic User's Survey (OPUS), and World Health Organization Quality of Life (WHQOL)-BREF Scale.
Significant changes were observed in participants' self-selected gait speed (P=.023), BBS (P=.01), FGA (P=.002), and SAI (P<.001) between baseline and post-MPO assessment. Similar significant differences were seen when comparing post-MPO with post-SCO data. During the 6MWT, persons using the MPO walked significantly longer (P=.013) than when using their baseline device. Participants reported higher quality of life scores in the OPUS (P=.02) and physical health domain of the WHOQOL-BREF (P=.037) after using the MPO. Participants reported fewer falls when wearing the MPO (5) versus an SCO (38) or locked KAFO (15).
The MPO may contribute to improved quality of life and health status of persons with lower-extremity impairments by providing the ability to have better walking speed, endurance, and functional balance.
与站位控制矫形器(SCO)和传统膝踝足矫形器(KAFO)相比,评估微处理器摆动和站立控制膝踝足矫形器(MPO)在一个月的使用期内改善下肢损伤个体平衡、功能性移动能力和生活质量的潜力。
随机交叉研究。
门诊研究实验室和社区,供社区居住的成年人使用。
患有神经或神经肌肉疾病、骨科疾病或创伤导致下肢损伤的主动使用单侧 KAFO 或 SCO 的人员。
参与者接受了 SCO 和 MPO 的适应和使用培训。
6 分钟步行测试(6MWT)、10 米步行测试、伯格平衡量表(BBS)、功能性步态评估(FGA)、斜坡评估指数、楼梯评估指数(SAI)、五次坐立测试、横过马路测试、改良跌倒效能量表、矫形器和假肢使用者调查(OPUS)以及世界卫生组织生活质量(WHOQOL)-BREF 量表。
参与者的自我选择步行速度(P=.023)、BBS(P=.01)、FGA(P=.002)和 SAI(P<.001)在 MPO 前后评估之间发生了显著变化。当将 MPO 后数据与 SCO 后数据进行比较时,也观察到类似的显著差异。在 6MWT 中,使用 MPO 的人行走的距离明显更长(P=.013)比使用基线设备时。参与者在使用 MPO 后报告了更高的 OPUS(P=.02)和 WHOQOL-BREF 的身体健康领域得分(P=.037)。参与者报告在佩戴 MPO 时跌倒次数较少(5 次),而佩戴 SCO 时跌倒次数较多(38 次),佩戴锁定 KAFO 时跌倒次数较多(15 次)。
MPO 通过提供更好的步行速度、耐力和功能性平衡能力,可能有助于改善下肢损伤患者的生活质量和健康状况。